The test is being developed at Llanelli's Prince Phillip Hospital with the help of Singleton Oncology and the University of Swansea.
During recent trials, nearly half of patients who were initially recommended for chemotherapy and endocrine therapy, had their treatment changed to endocrine therapy alone.
This test will have a major impact on the lives of many women, allowing them to get on with their lives following breast cancer surgery rather than having to go through four months of chemotherapy."
The 'Oncotype DX' test, which is only for women with early breast cancer, will give clinicians a clearer idea of the risk and benefit of chemotherapy.
More top news
The Met Office has issued a yellow 'be aware' warning of rain for parts of south Wales with a risk of localised flooding.
Showers overnight will make way for heavy rain tomorrow! The Met Office has issued a warning to be aware!
Dermatology services in west Wales are at breaking point say top skin experts in Wales. Hywel Dda currently has no consultant dermatologist.